Prevalence, risk factors, and perceptions of vaccination against reproductive tract infections among urban females in Delhi: a cross-sectional study - Report - MDSpire

Prevalence, risk factors, and perceptions of vaccination against reproductive tract infections among urban females in Delhi: a cross-sectional study

  • By

  • Priya Bhardwaj

  • Sunita K. Yadav

  • Joyeta Ghosh

  • Ravi Kant

  • Anita Garg Mangla

  • Sumathi Muralidhar

  • Daman Saluja

  • Aleksandra E. Sikora

  • Jyoti Taneja

  • May 26, 2026

  • 0 min

Share

Vaccination Awareness, Risk Factors, and Prevalence of Reproductive Tract Infections Among Urban Women in Delhi

Overview

This study reveals a high prevalence of self-reported reproductive tract infection (RTI) symptoms among urban women in Delhi, with significant associations identified between RTIs and various risk factors. Additionally, the study highlights low vaccination rates against HPV and hepatitis B, alongside concerns regarding vaccine safety and cost.

Background

Reproductive tract infections (RTIs) are a significant public health issue, particularly affecting young women in developing countries. Untreated RTIs can lead to severe complications such as infertility and increased susceptibility to HIV. Understanding the prevalence and associated risk factors is crucial for improving reproductive health outcomes.

Data Highlights

FindingValue
Self-reported RTI symptoms64.6%
Vaccination against HPV8.2%
Vaccination against hepatitis B25.9%
Awareness of HPV vaccine54.3%
Awareness of hepatitis B vaccine79.5%
Hesitant about emerging RTI vaccines53.8%

Key Findings

  • 64.6% of respondents reported RTI symptoms.
  • 83% experienced vaginal discharge, and 78.5% reported vulval itching.
  • Significant risk factors for high-risk RTIs included menstrual hygiene practices (OR = 3.183) and prior RTI medication use (OR = 8.839).
  • Only 8.2% and 25.9% had been vaccinated against HPV and hepatitis B, respectively.
  • 53.8% expressed hesitancy towards emerging RTI vaccines, primarily due to safety concerns (36%) and cost (18.6%).
  • 42.9% reported that healthcare provider recommendations positively influenced their willingness to receive vaccination.

Clinical Implications

The findings indicate a pressing need for enhanced screening and healthcare services for RTIs among urban women. Increasing awareness and addressing concerns regarding vaccine safety and cost may improve vaccination rates against STIs.

Conclusion

The study reports a high prevalence of RTI symptoms and highlights the need for improved reproductive health literacy and vaccination uptake among urban women in Delhi.

Related Resources & Content

  1. The Journal of Infectious Diseases, Elevated Rates and Genetic Variation of Ongoing Chlamydia Trachomatis Infections in South African Adolescent Girls and Young Women: Insights from Two Urban Areas, 2023
  2. American Journal of Epidemiology, Genotype Patterns of High-Risk Human Papillomavirus and Cervical Cytology Abnormalities in Women from Tripura, Northeastern India: A Hospital-Based Analysis, 2023
  3. Infection, High Prevalence of Sexually Transmitted Infections Linked to Bacterial Vaginosis in South African Adolescent Girls and Young Women, 2023
  4. Press Information Bureau, Government of India, 2026 -- Nationwide HPV Vaccination Campaign
  5. BMJ Public Health, Prevalence of reproductive tract and sexually transmitted infections among symptomatic and asymptomatic women, 2023
  6. Frontiers in Reproductive Health — SARS-CoV-2 and reproductive system: a scientometric study
  7. National Technical Guidelines on STI and RTI
  8. Press Release Page | Press Information Bureau
  9. Prevalence of reproductive tract and sexually transmitted infections among symptomatic and asymptomatic women, validity of syndromic management, in urban and periurban low to mid socioeconomic neighbourhoods of North Delhi: an observational study | BMJ Public Health

Original Source(s)

Related Content